Drug intelligence / Profile preview

deuterated N'-nitrosonornicotine

Development stage
Preclinical
Lead developer
University of Minnesota
Modality
Small Molecules
Administration
Oral
01

Overview

Deuterated N'-nitrosonornicotine (deuterated NNN) is a chemically modified form of the tobacco-specific nitrosamine carcinogen N'-nitrosonornicotine (NNN), in which one or more hydrogen atoms are replaced by the stable isotope deuterium. This modification is used primarily for research purposes to study the metabolism and pharmacokinetics of NNN in humans, particularly among users of smokeless tobacco. Deuteration can slow metabolic breakdown due to the kinetic isotope effect, allowing for more precise tracking and quantification in biological samples. The compound itself is not a therapeutic drug but rather a labeled analog used as a probe or tracer in clinical studies investigating carcinogen exposure and metabolism[1][2][3].

Other names
deuterated N'-nitrosonornicotined-NNN
02

Targets

CYP3A4 (Cytochrome P450 3A4)CYP2B6 (Cytochrome P450 2B6)CYP2A6 (Cytochrome P450 2A6)CYP2E1CYP2A13 (Cytochrome P450 2A13)

Beyond the preview

Go deeper on deuterated N'-nitrosonornicotine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on deuterated N'-nitrosonornicotine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call